TCL Archive In Brief: Cancer Program “Strengthened” NIH, Report From Biomedical Research Panel Contends April 16, 1976
TCL Archive In Brief: David Nathan receives Lifetime Impact Award from Boston Children’s Hospital November 7, 2014
TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive NIH begins transition to electronic grant submissions; seeks comment on options for NRSA funding. October 28, 2005
TCL Archive In Brief: Upton Still Pondering Location Of Centers, Other Program; Moves Could Involve DCCR April 27, 1979
